您当前的位置：
首页 >
文章列表页 >
Research on safety risk signals of five drugs for Gaucher disease
更新时间：2026-06-26

    • Research on safety risk signals of five drugs for Gaucher disease

    • ZHONGGUO YAOFANG   Vol. 37, Issue 12, Pages: 1607-1613(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.12.15    

      CLC： R969.3

    • Received：30 January 2026，

      Revised：2026-06-11，

      Accepted：15 June 2026，

      Published：30 June 2026

    移动端阅览

  • YI Cheng,HAN Qiwei,XU Jing,et al.Research on safety risk signals of five drugs for Gaucher disease[J].ZHONGGUO YAOFANG,2026,37(12):1607-1613. DOI： 10.6039/j.issn.1001-0408.2026.12.15.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in the application of machine learning in the prediction of adverse drug reactions
Bibliometric analysis of status quo and hot spots of domestic and foreign pharmacovigilance research
Problems and countermeasures on pharmacovigilance system of 15 marketing authorization holders in Shanghai
Situation Comparison and Enlightenment of ADR Collection by Social Media between European and American Countries and China
Comparative Study on Pharmacovigilance Signal Management System among the European Union ，the United States and Japan

Related Author

HUANG Chenrong
YANG Tingting
SONG Lin
XU Mengjia
LI Zhengxiang
DUAN Rong
HU Jun
FANG Yuemin

Related Institution

Dept. of Pharmacy， the First Affiliated Hospital of Soochow University
College of Pharmaceutical Sciences， Soochow University
0